SANDRA CORBIN: Open Payments
NPI 1962431346 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 7 payments from 7 companies in 2025. Trend: 2023 $594 · 2024 $183 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| JAZZ PHARMACEUTICALS INC. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Incyte Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Exelixis Inc. | 1 | $14 |
Products named: DARZALEX, INVEGA SUSTENNA, ZEPZELCA, KEYTRUDA, NIKTIMVO, CABOMETYX.
Industry payments across CT — which companies pay providers there.
